Olympus Biotech • Hopkinton, MA
(formerly Stryker Biotech)
Corporate Offices, cGMP Cleanrooms, Labs and Warehouse
Beginning with the development of a comprehensive 5-year master plan in 2000, PIDC has completed more than 25 projects for Olympus/Stryker over the past decade-plus. The most recent was the effective subdivision and marketing of a portion of its leased premises for a subtenant.
PIDC’s varied achievements for Olympus/Stryker include significant infrastructure upgrades along with design/build services to support first-class research, development, cGMP manufacturing, corporate offices and warehousing.
Project highlights include:
A leader in the development and distribution of regenerative medicines, Olympus Biotech is dedicated to improving patient quality-of-life by stimulating the intrinsic healing capacity in the living body. Its portfolio of growth factors and biomaterials includes the breakthrough Osteogenic Protein-1 (OP-1™ or rhBMP-7) — a naturally-occurring osteoinductive protein used to stimulate, repair, and regenerate bone.
Mike St. Louis, Director, Plant Services
603.298.4218 • email@example.com